Free Trial

BioHarvest Sciences (BHST) Competitors

BioHarvest Sciences logo
$7.58 -0.27 (-3.44%)
As of 03:16 PM Eastern

BHST vs. SLDB, PRTC, RGNX, CMPX, TECX, AQST, FULC, KMDA, ERAS, and SNDL

Should you be buying BioHarvest Sciences stock or one of its competitors? The main competitors of BioHarvest Sciences include Solid Biosciences (SLDB), PureTech Health (PRTC), REGENXBIO (RGNX), Compass Therapeutics (CMPX), Tectonic Therapeutic (TECX), Aquestive Therapeutics (AQST), Fulcrum Therapeutics (FULC), Kamada (KMDA), Erasca (ERAS), and SNDL (SNDL). These companies are all part of the "pharmaceutical products" industry.

BioHarvest Sciences vs. Its Competitors

BioHarvest Sciences (NASDAQ:BHST) and Solid Biosciences (NASDAQ:SLDB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

BioHarvest Sciences presently has a consensus price target of $13.67, suggesting a potential upside of 80.30%. Solid Biosciences has a consensus price target of $15.10, suggesting a potential upside of 115.71%. Given Solid Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Solid Biosciences is more favorable than BioHarvest Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioHarvest Sciences
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Solid Biosciences
0 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
2 Strong Buy rating(s)
3.17

BioHarvest Sciences has higher revenue and earnings than Solid Biosciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Solid Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioHarvest Sciences$25.19M4.94-$12.91M-$0.50-15.16
Solid BiosciencesN/AN/A-$124.70M-$2.99-2.34

In the previous week, Solid Biosciences had 4 more articles in the media than BioHarvest Sciences. MarketBeat recorded 5 mentions for Solid Biosciences and 1 mentions for BioHarvest Sciences. BioHarvest Sciences' average media sentiment score of 0.96 beat Solid Biosciences' score of 0.75 indicating that BioHarvest Sciences is being referred to more favorably in the media.

Company Overall Sentiment
BioHarvest Sciences Positive
Solid Biosciences Positive

Solid Biosciences has a net margin of 0.00% compared to BioHarvest Sciences' net margin of -31.30%. Solid Biosciences' return on equity of -68.15% beat BioHarvest Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
BioHarvest Sciences-31.30% -307.04% -33.21%
Solid Biosciences N/A -68.15%-55.33%

BioHarvest Sciences has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, Solid Biosciences has a beta of 2.34, suggesting that its stock price is 134% more volatile than the S&P 500.

81.5% of Solid Biosciences shares are held by institutional investors. 1.9% of Solid Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Solid Biosciences beats BioHarvest Sciences on 11 of the 16 factors compared between the two stocks.

Get BioHarvest Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for BHST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BHST vs. The Competition

MetricBioHarvest SciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$124.46M$3.04B$5.74B$9.51B
Dividend YieldN/A2.40%4.60%3.99%
P/E Ratio-15.1621.1828.1120.03
Price / Sales4.94339.43461.37103.88
Price / CashN/A43.2336.5559.01
Price / Book94.758.368.655.90
Net Income-$12.91M-$55.19M$3.25B$258.66M
7 Day Performance9.54%5.89%4.21%2.22%
1 Month Performance13.98%17.63%10.82%12.76%
1 Year PerformanceN/A5.09%34.70%19.36%

BioHarvest Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BHST
BioHarvest Sciences
N/A$7.58
-3.4%
$13.67
+80.3%
N/A$124.46M$25.19M-15.16N/ANews Coverage
Gap Down
SLDB
Solid Biosciences
3.2656 of 5 stars
$6.39
+10.4%
$15.10
+136.3%
-24.4%$448.81M$8.09M-2.14100High Trading Volume
PRTC
PureTech Health
2.7951 of 5 stars
$19.06
+3.0%
$45.00
+136.1%
-16.2%$444.47M$4.83M0.00100Positive News
Upcoming Earnings
RGNX
REGENXBIO
4.1758 of 5 stars
$8.16
-6.1%
$31.63
+287.6%
-33.1%$435.89M$83.33M-2.62370News Coverage
Positive News
CMPX
Compass Therapeutics
3.025 of 5 stars
$3.00
-4.8%
$12.67
+322.2%
+230.9%$435.59M$850K-7.3220Positive News
TECX
Tectonic Therapeutic
2.6009 of 5 stars
$21.91
-5.9%
$83.60
+281.6%
+31.1%$434.70MN/A-3.00120Positive News
AQST
Aquestive Therapeutics
1.7091 of 5 stars
$4.20
-3.9%
$10.14
+141.5%
+24.6%$434.06M$57.56M-7.12160
FULC
Fulcrum Therapeutics
0.5432 of 5 stars
$7.65
-3.7%
$6.29
-17.8%
-8.6%$428.60M$80M-109.27100Upcoming Earnings
KMDA
Kamada
4.1156 of 5 stars
$7.45
+0.3%
$13.00
+74.5%
+33.7%$427.26M$160.95M25.69360News Coverage
ERAS
Erasca
2.901 of 5 stars
$1.50
+0.7%
$4.57
+204.8%
-45.0%$422.10MN/A-2.42120Positive News
SNDL
SNDL
1.8885 of 5 stars
$1.54
-1.3%
$4.00
+159.7%
-30.8%$409.93M$671.81M-5.312,516News Coverage
Upcoming Earnings
Gap Up

Related Companies and Tools


This page (NASDAQ:BHST) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners